Boehringer Ingelheim To Invest $91 Million In Shanghai
This article was originally published in PharmAsia News
Executive Summary
Shanghai is about to get a $91 million investment by Germany’s Boehringer Ingelheim, which plans to build a facility to serve as the firm’s global production operations.